Psychedelic Medicine for Depression and Burnout in Healthcare Professionals
Log in To Watch the Recording
*Exclusive for members.
Thursday, June 29th at 5 pm Pacific, 8 pm Eastern >> Log in to Watch the Recording >>
An EXCLUSIVE Panel Discussion For Members Of The Psychedelic Medicine Association:
Psychedelic Medicine for Depression and Burnout in Healthcare Professionals
Panel Moderator:
Lynn Marie Morski, MD, JD
President - Psychedelic Medicine Association
Panelists:
Pamela Kryskow, MD
Medical Lead, Roots To Thrive; Medical Chair, Psychedelic Assisted Therapy Vancouver Island University
Dr. Pamela Kryskow is a medical doctor and the medical lead of the Non Profit Roots To Thrive Psychedelic Assisted Therapy Programs that treats people with PTSD, depression, anxiety, substance use challenges and with end of life distress.
She is a founding board member of the Psychedelic Association of Canada and the medical chair of the Vancouver Island University Post Graduate Certificate in Psychedelic Medicine assisted Therapy.
Ongoing research includes psilocybin, MDMA, ketamine, microdosing, front line health care workers and first responders mental wellness.
Prior to studying medicine she was a City of Coquitlam Firefighter for 8 years and provincial forestry firefighter for 4 seasons. In real life she loves hiking in the forest, ocean kayaking, growing kale and daydreaming in the hammock. Her heritage includes Polish, Ukrainian, and German. She currently resides in the traditional unceded territory of the Klahoose First Nations.
Pronouns: She/her.
Hannah Cross, LCSW
Therapist, Numinus & For All the Wild Sunflowers
Hannah Cross specializes her therapy practice in psychedelic integration and trauma healing. Her background includes extensive work in substance abuse treatment and work with incarcerated individuals. She provides ketamine assisted psychotherapy for individuals, groups, and families. She has both a private practice (forallthewildsunflowers.com) and works with Numinus as a therapist/facilitator on various psychedelic studies, including those with LSD and psilocybin. Her approach is grounded in transpersonal psychology, parts-work, and somatic healing.
Hannah Cross, LCSW
Therapist, Numinus & For All the Wild Sunflowers
Hannah Cross specializes her therapy practice in psychedelic integration and trauma healing. Her background includes extensive work in substance abuse treatment and work with incarcerated individuals. She provides ketamine assisted psychotherapy for individuals, groups, and families. She has both a private practice (forallthewildsunflowers.com) and works with Numinus as a therapist/facilitator on various psychedelic studies, including those with LSD and psilocybin. Her approach is grounded in transpersonal psychology, parts-work, and somatic healing.
In past webinars, we’ve seen how psychedelics can be helpful in addressing patients with a variety of medical conditions. However, this month we’re turning our focus to how psychedelic medicines may be able to help the healthcare professionals who have dedicated their lives to treating those same patients.
Burnout amongst clinicians was already an issue pre-pandemic, but during and afterward the situation has become much more dire. Many are leaving the profession altogether, which puts further strain on those who are left. Often healthcare professionals struggle to care for patients when they themselves have nothing left to give.
We know that a systemic change needs to occur to improve the pressure put on healthcare professionals, but that’s a long-term term issue for a problem that is affecting practitioners like yourselves right now.
Fortunately, a number of studies have taken a look at whether psychedelic therapies may be effective at mitigating some of the symptoms of burnout and some of the conditions that can stem from burnout, like depression.
This month we have some absolute legends in the space representing various trials and programs geared toward healthcare professionals. They’ll be discussing the following:
- What kinds of psychedelic therapies have been studied in healthcare workers
- How treatments were administered (individual vs. group)
- The results of the trials and the treatment programs
- What other interventions have been helpful
…and much more!
As always, there will be ample time for audience Q & A, so you’ll get to interact with the panelists directly!
So please join us for this live panel discussion on Thursday, June 29th at 5 pm Pacific, 8 pm Eastern. This is exclusively for members of the Psychedelic Medicine Association, so if you have not yet registered, please do so here. A link to the recording will be available afterward if you cannot make it to the live event.
Hope to see you all on the 29th!
You can find the Psychedelic Medicine Association on Twitter, LinkedIn, and on Facebook.